GlassScriptPhysician profile
Yun Pan Scott
NPI 1457845562
$9,394.94
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.00 · 2020: $19.46 · 2021: $284 · 2022: $2,961 · 2023: $3,379 · 2024: $2,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,884 · Travel and Lodging: $2,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,884.38 |
| Travel and Lodging | $2,226.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,248.98 | 2021-2024 | Hoffmann, Salvation, Prostep |
| Treace Medical Concepts, INC. | $1,190.83 | 2022 | |
| Smith+Nephew, INC. | $157.12 | 2021-2023 | Regranex |
| Kerecis Limited | $134.19 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $95.81 | 2021-2023 | Nuzyra |
| Fortis Surgical, LLC | $69.10 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $69.04 | 2022-2023 | Seglentis |
| Stimwave Technologies Incorporated | $61.92 | 2021 | |
| Depuy Synthes Sales INC. | $45.46 | 2022 | |
| Lifenet Health | $44.46 | 2023 | |
| Boston Scientific Corporation | $34.06 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Convatec INC. | $32.27 | 2022-2023 | |
| Bioventus LLC | $30.79 | 2022 | |
| Nevro Corp. | $24.69 | 2023 | Senza |
| Medtronic, INC. | $24.52 | 2024 | Intellis Adaptivestim |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.78 | 2023 | Proclaim |
| Musculoskeletal Transplant Foundation INC. | $22.12 | 2021 | |
| Zyla Life Sciences, INC. | $19.46 | 2020 | |
| Genentech USA, INC. | $19.00 | 2019 | |
| Sebela Pharmaceuticals INC. | $17.41 | 2022 | |
| Mimedx Group, INC. | $15.93 | 2024 | |
| Fidia Pharma USA INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yun Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.